Probiotics in Functional Gastrointestinal Disorders

  • Iva HojsakEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1125)


Infantile colic, constipation, functional abdominal pain (FAP), and irritable bowel syndrome (IBS) are the most common functional gastrointestinal disorders (FGID). This chapter will review current evidence on the role of probiotics in the treatment of these FGID. The etiology of FGID is considered multifactorial, but the importance of intestinal microbiota in their development has been repeatedly emphasized. As a consequence, the potential role of probiotics in their treatment is being increasingly scrutinized. Presently, the strongest evidence of efficacy is for the use of Lactobacillus reuteri (L reuteri) DSM 17938 at the dose of 108 CFU/day for the treatment of infantile colic in breastfed infants. Limited, yet encouraging, evidence exists for Lactobacillus rhamnosus GG (LGG) at the dose of 3 × 109 CFU and for a multi-strain preparation for the treatment of IBS. In the treatment of FAP, there is some evidence for the use of L reuteri DSM 17938 at the dose of at least 108 CFU/day.


Functional abdominal pain Infantile colic Irritable bowel syndrome Lactobacillus Probiotics 


  1. Abbott RA, Martin AE, Newlove-Delgado TV, Bethel A, Whear RS, Coon JT, Logan S (2018) Recurrent abdominal pain in children: summary evidence from 3 systematic reviews of treatment effectiveness. J Pediatr Gastroenterol Nutr 67:23. Scholar
  2. Anabrees J, Indrio F, Paes B, AlFaleh K (2013) Probiotics for infantile colic: a systematic review. BMC Pediatr 13:186. Scholar
  3. Assa A, Ish-Tov A, Rinawi F, Shamir R (2015) School attendance in children with functional abdominal pain and inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 61(5):553–557. Scholar
  4. Attaluri A, Jackson M, Valestin J, Rao SS (2010) Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 105(6):1407–1411. Scholar
  5. Banaszkiewicz A, Szajewska H (2005) Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 146(3):364–369. Scholar
  6. Bar F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, Bottner M, Wedel T (2009) Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil 21(5):559–566, e516–557. Scholar
  7. Bauserman M, Michail S (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 147(2):197–201. Scholar
  8. Benninga MA, Voskuijl WP, Taminiau JA (2004) Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 39(5):448–464CrossRefGoogle Scholar
  9. Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S (2016) Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 150:1443. Scholar
  10. Biagioli E, Tarasco V, Lingua C, Moja L, Savino F (2016) Pain-relieving agents for infantile colic. Cochrane Database Syst Rev 9:CD009999. Scholar
  11. Bonilla S, Saps M (2013) Early life events predispose the onset of childhood functional gastrointestinal disorders. Rev Gastroenterol Mex 78(2):82–91. Scholar
  12. Bouhnik Y, Neut C, Raskine L, Michel C, Riottot M, Andrieux C, Guillemot F, Dyard F, Flourie B (2004) Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther 19(8):889–899. Scholar
  13. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC (2007) Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 49(4):485–490. Scholar
  14. Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, Koren G (2015) Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 166(1):74–78. Scholar
  15. Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ (2015) Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 42(4):418–427. Scholar
  16. Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A (2010) Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr 157(4):598–602. Scholar
  17. de Meij TG, de Groot EF, Eck A, Budding AE, Kneepkens CM, Benninga MA, van Bodegraven AA, Savelkoul PH (2016) Characterization of microbiota in children with chronic functional constipation. PLoS One 11(10):e0164731. Scholar
  18. de Weerth C, Fuentes S, Puylaert P, de Vos WM (2013) Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 131(2):e550–e558. Scholar
  19. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K (2014) The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100(4):1075–1084. Scholar
  20. Dimidi E, Christodoulides S, Scott SM, Whelan K (2017) Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr 8(3):484–494. Scholar
  21. Dubois NE, Gregory KE (2016) Characterizing the intestinal microbiome in infantile colic: findings based on an integrative review of the literature. Biol Res Nurs 18(3):307–315. Scholar
  22. Eftekhari K, Vahedi Z, Kamali Aghdam M, Noemi Diaz D (2015) A randomized double-blind placebo-controlled trial of lactobacillus reuteri for chronic functional abdominal pain in children. Iran J Pediatr 25(6):e2616. Scholar
  23. Faure C, Wieckowska A (2007) Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr 150(1):66–71. Scholar
  24. Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, Indrio F, Cavallo L (2010) A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 126(6):e1445–e1452. Scholar
  25. Gawronska A, Dziechciarz P, Horvath A, Szajewska H (2007) A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 25(2):177–184. Scholar
  26. Giannetti E, Staiano A (2016) Probiotics for irritable bowel syndrome: clinical data in children. J Pediatr Gastroenterol Nutr 63(Suppl 1):S25–S26. Scholar
  27. Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A (2017) A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol 51(1):e5–e10. Scholar
  28. Guandalini S, Magazzu G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M (2010) VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 51(1):24–30. Scholar
  29. Guerra PV, Lima LN, Souza TC, Mazochi V, Penna FJ, Silva AM, Nicoli JR, Guimaraes EV (2011) Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J Gastroenterol 17(34):3916–3921. Scholar
  30. Gutierrez-Castrellon P, Indrio F, Bolio-Galvis A, Jimenez-Gutierrez C, Jimenez-Escobar I, Lopez-Velazquez G (2017) Efficacy of lactobacillus reuteri DSM 17938 for infantile colic: systematic review with network meta-analysis. Medicine (Baltimore) 96(51):e9375. Scholar
  31. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291(5505):881–884. Scholar
  32. Horvath A, Dziechciarz P, Szajewska H (2011) Meta-analysis: lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33(12):1302–1310. Scholar
  33. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T (2001) Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 280(3):G368–G380. Scholar
  34. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M (2016) Functional disorders: children and adolescents. Gastroenterology 150:1456. Scholar
  35. Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R (2014) Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr 168(3):228–233. Scholar
  36. Jadresin O, Hojsak I, Misak Z, Kekez AJ, Trbojevic T, Ivkovic L, Kolacek S (2017) Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. J Pediatr Gastroenterol Nutr 64(6):925–929. Scholar
  37. Koppen IJN, Vriesman MH, Saps M, Rajindrajith S, Shi X, van Etten-Jamaludin FS, Di Lorenzo C, Benninga MA, Tabbers MM (2018) Prevalence of functional defecation disorders in children: a systematic review and meta-analysis. J Pediatr 198:121. Scholar
  38. Korterink J, Devanarayana NM, Rajindrajith S, Vlieger A, Benninga MA (2015) Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol 12(3):159–171. Scholar
  39. Landgren K, Hallstrom I (2011) Parents’ experience of living with a baby with infantile colic – a phenomenological hermeneutic study. Scand J Caring Sci 25(2):317–324. Scholar
  40. Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT (2017) Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis 49(4):331–337. Scholar
  41. Lucassen P (2015) Colic in infants. BMJ Clin Evid 2015:pii: 0309Google Scholar
  42. Maragkoudaki M, Chouliaras G, Orel R, Horvath A, Szajewska H, Papadopoulou A (2017) Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatr 106(11):1857–1862. Scholar
  43. Mi GL, Zhao L, Qiao DD, Kang WQ, Tang MQ, Xu JK (2015) Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek 107(6):1547–1553. Scholar
  44. Ohman L, Simren M (2013) Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 15(5):323. Scholar
  45. Partty A, Kalliomaki M (2017) Infant colic is still a mysterious disorder of the microbiota-gut-brain axis. Acta Paediatr 106(4):528–529. Scholar
  46. Partty A, Kalliomaki M, Endo A, Salminen S, Isolauri E (2012) Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS One 7(3):e32495. Scholar
  47. Partty A, Lehtonen L, Kalliomaki M, Salminen S, Isolauri E (2015) Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatr Res 78(4):470–475. Scholar
  48. Partty A, Kalliomaki M, Salminen S, Isolauri E (2017) Infantile colic is associated with low-grade systemic inflammation. J Pediatr Gastroenterol Nutr 64(5):691–695. Scholar
  49. Perez-Burgos A, Wang L, McVey Neufeld KA, Mao YK, Ahmadzai M, Janssen LJ, Stanisz AM, Bienenstock J, Kunze WA (2015) The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol 593(17):3943–3957. Scholar
  50. Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141(5):1792–1801. Scholar
  51. Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O (2012) Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107(11):1740–1751. Scholar
  52. Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, Comisi F, Famiani A, Comito D (2014) Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 50(10):E68–E71. Scholar
  53. Roos S, Dicksved J, Tarasco V, Locatelli E, Ricceri F, Grandin U, Savino F (2013) 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One 8(2):e56710. Scholar
  54. Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, Mills DA (2013) Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol 79(19):6040–6049. Scholar
  55. Sadeghzadeh M, Rabieefar A, Khoshnevisasl P, Mousavinasab N, Eftekhari K (2014) The effect of probiotics on childhood constipation: a randomized controlled double blind clinical trial. Int J Pediatr 2014:937212. Scholar
  56. Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141(5):1782–1791. Scholar
  57. Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D (2010) Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126(3):e526–e533. Scholar
  58. Savino F, Ceratto S, De Marco A, Cordero di Montezemolo L (2014) Looking for new treatments of Infantile Colic. Ital J Pediatr 40:53. Scholar
  59. Savino F, Garro M, Montanari P, Galliano I, Bergallo M (2018) Crying time and RORgamma/FOXP3 expression in lactobacillus reuteri DSM17938-treated infants with colic: a randomized trial. J Pediatr 192(171–177):e171. Scholar
  60. Schreck Bird A, Gregory PJ, Jalloh MA, Risoldi Cochrane Z, Hein DJ (2017) Probiotics for the treatment of infantile colic: a systematic review. J Pharm Pract 30(3):366–374. Scholar
  61. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66(5):2263–2266CrossRefGoogle Scholar
  62. Smith C, Nordstrom E, Sengupta JN, Miranda A (2007) Neonatal gastric suctioning results in chronic visceral and somatic hyperalgesia: role of corticotropin releasing factor. Neurogastroenterol Motil 19(8):692–699. Scholar
  63. Soares AC, Lederman HM, Fagundes-Neto U, de Morais MB (2005) Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 39(6):512–515CrossRefGoogle Scholar
  64. Sung V, Hiscock H, Tang M, Mensah FK, Heine RG, Stock A, York E, Barr RG, Wake M (2012) Probiotics to improve outcomes of colic in the community: protocol for the Baby Biotics randomised controlled trial. BMC Pediatr 12:135. Scholar
  65. Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348:g2107. Scholar
  66. Sung V, D’Amico F, Cabana MD, Chau K, Koren G, Savino F, Szajewska H, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Tancredi D (2018) Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics 141(1):e20171811. Scholar
  67. Szajewska H, Gyrczuk E, Horvath A (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162(2):257–262. Scholar
  68. Tabbers MM, Chmielewska A, Roseboom MG, Crastes N, Perrin C, Reitsma JB, Norbruis O, Szajewska H, Benninga MA (2011) Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Pediatrics 127(6):e1392–e1399. Scholar
  69. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y, Benninga MA, European Society for Pediatric Gastroenterology H, Nutrition, North American Society for Pediatric G (2014) Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58(2):258–274. Scholar
  70. Trivic I, Hojsak I (2018) Initial diagnosis of functional gastrointestinal disorders in children increases a chance for resolution of symptoms. Pediatr Gastroenterol Hepatol Nutr 21(4):264–270CrossRefGoogle Scholar
  71. Vandenplas Y, Gutierrez-Castrellon P, Velasco-Benitez C, Palacios J, Jaen D, Ribeiro H, Shek LP, Lee BW, Alarcon P (2013) Practical algorithms for managing common gastrointestinal symptoms in infants. Nutrition 29(1):184–194. Scholar
  72. Vulin K, Hojsak I (2015) Infantile colic – newer approach to an old problem. Lijec Vjesn 137(11–12):367–372PubMedGoogle Scholar
  73. Walsham AD, MacKenzie DA, Cook V, Wemyss-Holden S, Hews CL, Juge N, Schuller S (2016) Lactobacillus reuteri inhibition of enteropathogenic Escherichia coli adherence to human intestinal epithelium. Front Microbiol 7:244. Scholar
  74. Warschburger P, Hanig J, Friedt M, Posovszky C, Schier M, Calvano C (2014) Health-related quality of life in children with abdominal pain due to functional or organic gastrointestinal disorders. J Pediatr Psychol 39(1):45–54. Scholar
  75. Wegner A, Banaszkiewicz A, Kierkus J, Landowski P, Korlatowicz-Bilar A, Wiecek S, Kwiecien J, Gawronska A, Dembinski L, Czaja-Bulsa G, Socha P (2018) The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multiCenter trial. Clin Res Hepatol Gastroenterol 42:494. Scholar
  76. Weizman Z, Abu-Abed J, Binsztok M (2016) Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr 174(160–164):e161. Scholar
  77. Wojtyniak K, Szajewska H (2017) Systematic review: probiotics for functional constipation in children. Eur J Pediatr 176(9):1155–1162. Scholar
  78. Wojtyniak K, Horvath A, Dziechciarz P, Szajewska H (2017) Lactobacillus casei rhamnosus Lcr35 in the management of functional constipation in children: a randomized trial. J Pediatr 184(101–105):e101. Scholar
  79. Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, Baker SS (2014) Structural changes in the gut microbiome of constipated patients. Physiol Genomics 46(18):679–686. Scholar
  80. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E (1998) The intestinal ecosystem in chronic functional constipation. Acta Paediatr 87(8):836–841CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Referral Center for Pediatric Gastroenterology and NutritionChildren’s Hospital ZagrebZagrebCroatia
  2. 2.School of MedicineUniversity of ZagrebZagrebCroatia
  3. 3.School of Medicine OsijekUniversity J.J. StrossmayerOsijekCroatia

Personalised recommendations